ERYTECH PHARMA's ticker is ERYP and the CUSIP is 29604W108. A total of 7 filers reported holding ERYTECH PHARMA in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $539 | -65.6% | 550 | -88.4% | 0.00% | – |
| Q4 2022 | $1,569 | -21.6% | 4,755 | +10.1% | 0.00% | – |
| Q3 2022 | $2,000 | -80.0% | 4,320 | -50.4% | 0.00% | – |
| Q2 2022 | $10,000 | +25.0% | 8,711 | +143.1% | 0.00% | – |
| Q4 2021 | $8,000 | -27.3% | 3,583 | +187.6% | 0.00% | – |
| Q3 2018 | $11,000 | -15.4% | 1,246 | +6.0% | 0.00% | – |
| Q2 2018 | $13,000 | -48.0% | 1,176 | -0.1% | 0.00% | – |
| Q1 2018 | $25,000 | -30.6% | 1,177 | -28.1% | 0.00% | – |
| Q4 2017 | $36,000 | – | 1,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|